Page last updated: 2024-08-21

n-hexadecane and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

n-hexadecane has been researched along with (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Elias, PM; Feingold, KR; Mao-Qiang, M; Menon, GK; Schaude, M1

Other Studies

1 other study(ies) available for n-hexadecane and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

ArticleYear
Structural basis for the barrier abnormality following inhibition of HMG CoA reductase in murine epidermis.
    The Journal of investigative dermatology, 1992, Volume: 98, Issue:2

    Topics: Alkanes; Animals; Cell Membrane Permeability; Cholesterol; Dermatitis; Epidermis; Fatty Acids, Monounsaturated; Fluvastatin; Histocytochemistry; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Lanthanum; Lipase; Lovastatin; Male; Mice; Mice, Hairless; Skin; Tetradecanoylphorbol Acetate; Up-Regulation

1992